Besides obesity, this restorative potential of GLP-1 analogues has implications for other pathologies characterized by impaired dopaminergic function and associated with metabolic impairments, such as psychosis71, Parkinson’s disease72, depression73 or even cardiovascular events74. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.